AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇿
Efavirenz + Lamivudine + Tenofovir Disoproxil Fumarate in Tanzania
3 products registered with TMDA — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets 600 mg/ 300 mg/ 300 mg Tablet, Film-coated | TAN 20 HM 0120 | LAURUS LABS LIMITED | active | — |
| EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 400 MG/ 300 MG/ 300 MG Tablets | TAN 20 HM 0100 | LAURUS LABS LIMITED | active | — |
| Lamivudine 300 mg, Efavirenz 400 mg & Tenofovir 300 mg Tablets Film Coated Tablet | TZ 20 H 0138 | Macleods Pharmaceuticals Limited | active | — |
Efavirenz + Lamivudine + Tenofovir Disoproxil Fumarate — TMDA Registration Details
TMDA (Tanzania) has 3 registered products containing Efavirenz + Lamivudine + Tenofovir Disoproxil Fumarate, of which 3 are currently active. Data is sourced directly from the official TMDA drug register and refreshed daily.
Track Efavirenz + Lamivudine + Tenofovir Disoproxil Fumarate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.